[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 18, 1990

AIDS Dementia May Be Linked to Metabolite of Tryptophan

JAMA. 1990;264(3):305-306. doi:10.1001/jama.1990.03450030017002

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

QUINOLINIC ACID is intriguing researchers as a possible cause and marker of neurological damage in human immunodeficiency virus (HIV) disease.

It is a neurotoxic convulsant metabolite of tryptophan that is activated by interferon gamma. It is elevated with any infection, from a common rhinovirus to the mysterious lentivirus linked to acquired immunodeficiency syndrome (AIDS).

But quinolinic acid remains elevated for extended periods with HIV and increases as much as a 1000-fold over controls in patients with AIDS dementia complex, says Melvyn Heyes, PhD, a visiting scientist in the analytical biochemistry section at the National Institute for Mental Health in suburban Washington, DC (Maryland).

It binds to and may down-regulate Nmethyl-D-aspartate receptors, which are involved in normal neurotransmission, neural regeneration, memory, and synaptic plasticity. It can also induce seizures and nerve cell death, says Heyes.

"There is a wide spectrum of possible consequences known to occur in AIDS and other infectious

×